Webinar: “The Power of We” – A Practical, Collaborative Approach to Implement and Deliver Clinical Trials Predictably
Wed, Nov 11, 2020
11:00 AM – 12:00 PM EST
Clinical trials are risky, take a long time to implement and make up over half the cost of new drug development. The probability of a phase III clinical trial reaching regulatory approval often falls between 50 and 65%, and nearly 75% of studies are delayed from one to six months, causing increases in direct operational cost of more than $1M per month and overall cost of $10M per month.
How can the drug development process be made more efficient and effective? Solutions that minimize uncertainties, time, cost and risks of clinical trials are the holy grail. In this webinar, we will discuss the application of new, synergistic, participant recruitment and retention techniques that make drug development more productive.
This webinar will present a roundtable discussion by combining the experience of sponsors and CROs as well as the resources and tools of Trialbee and Clinerion to expound on a use case that optimizes the clinical trials process in a practical and predictable way.
Join Lollo Eriksson of Trialbee and Barış Erdoğan of Clinerion to learn how to:
- Apply large global research networks to:
- Conduct study and patient feasibility.
- Identify and select experienced principal investigators (PIs) with documented access to participants.
- Utilize a wide range of real-world data (RWD) including electronic health records (EHR) and claims data to facilitate participant recruitment and engagement.
- Conduct automated, efficient participant pre-qualification via EHR.
- Use multiple sources to connect, qualify and refer “study-ready” participants to investigator sites globally.
- Simulate clinical trial processes to identify and mitigate risks.
- Apply operational excellence practices to take advantage of the tied resources and manage trials effectively.
Lars-Olof (Lollo) Eriksson
Chief Executive Officer, Trialbee AB
Dr. Eriksson is an Associate Professor in clinical Pharmacology at Lund University, Sweden and at Rutgers University, School of Health Related Professions in New Jersey.
Trained as a clinical pharmacologist he spent 30-years with Merck & Co., Inc. where he held various positions within Merck Research Laboratories (MRL), including clinical pharmacology, clinical research development and clinical research operations across geographies. In addition, he has 8 years of executive leadership experience from the global CRO business focusing on study feasibility, study-start-up, patient recruitment and health care alliances and acquisitions.
For several decades he has focused on research methodology and business process development in clinical research with concentration on site related operations. His main areas of focus include utilization of health informatics, process and work-flow.
Vice President, Site & Patient Networks, Clinerion
Barış Erdoğan studied computer engineering and holds an M.Sc. and Ph.D. in educational technology. He practiced data mining techniques in various sectors including healthcare. He lectures on the topics of software development, database management, medical informatics, and project management. His expertise and experience include the management of innovative Medical Informatics projects and implementation of end-to-end Healthcare IT enterprise information systems, both in the public and private sectors.
CCO, Trialbee AB
Robert has a 25-year record of driving growth and new launches. He has held leadership positions including: Global Head of New Growth Opportunities for Novartis Consumer Healthcare; Head of US Marketing for Shionogi Pharmaceuticals; Marketing and Sales leadership roles at Novartis Pharmaceuticals and Pfizer Consumer Health – preceded by a Consumer Package Goods marketing career with Nestlé Purina Pet Care. He has received awards including Novartis CEO Business Excellence Award and Pharmacia Marketer of the Year. Originally from Sweden, Robert holds an MBA from Washington University and BAs from Miami University in Economics and International Studies.
Director of Operations,
Claudia has over 18 years of experience in clinical research. Most notably, she held positions as CEO of Intrials and as Director of Quintiles (IQVIA) for 10 years for Brazil, Colombia and Uruguay. She oversaw a remarkable 6-fold expansion of the company in Latin America and is a recognized figure in the industry. A major interlocutor between academia, investigators and government, she is actively working to develop a national plan in Uruguay to prioritize and modernize clinical research and increase the flow of trials to Latin America in general. Previous to RARAS, she co-founded the only CRO in Uruguay and articulated its expansion and subsequent merger with CRC to create RARAS CRO with offices in Brazil, Uruguay and Panama. She is also a Board Member of Porsaleu-Foundation for Patients with Leukemia & Lymphoma.
Director Health Informatics, AstraZeneca
Mats Sundgren, PhD, Health Informatics Director, Data Science & Artificial Intelligence, Biopharmaceutical R&D, AstraZeneca. He is based in AstraZeneca R&D Gothenburg Sweden and has more than 30 years of experience in the pharmaceutical industry (Discovery, Development, IT, Marketing, and Patents). He is integration lead for implementing EHR driven services. Mats was the coordinator of the European IMI EHR4CR project to (35 partners, incl. 10 pharma companies) aiming to R&D scalable federated EHR services. Leading project successfully from inception to completion. Chair of the InSite Champion Program, for the commercial deployment of EHR4CR services together in collaboration with industry sponsors and European hospitals. He is on the board of Directors of the European Institute for Innovation through Health Data , i-HD and a member of TriNetX Advisory Board.
He is also author of 50+ publications and books in science and economics (innovation management, clinical science, medical informatics, eHealth and business modelling).
Vice President of Customer Success & Analytics, Captario
Magnus Ytterstad has 20 years of experience in the pharmaceutical industry. Before joining Captario in 2015, Magnus held several portfolio and strategy leadership roles at AstraZeneca. As Head of Decision Analytics at Captario, Magnus works closely with customers to change processes around investment and other strategic decisions, which ultimately will lead to better decisions.